Scientists Report Advances Against Diabetes at Levine Symposium in Southern California

| Feb 9, 2008

City of Hope researchers were among the more than 50 international investigators reporting advances against type 1 diabetes at the recent Rachmiel Levine Diabetes and Obesity Symposium in Newport Beach, Calif.

Two City of Hope investigators - Joyce Niland, PhD, the Edward and Estelle Alexander Chair in Information Sciences, and Rama Natarajan, Ph.D., professor in the Department of Diabetes, Endocrinology & Metabolism - spoke at the eighth annual symposium, held January 13-16. City of Hope and the Leslie and Susan Gonda (Goldschmied) Diabetes and Genetic Research Center hosted the event.

Symposium topics ranged from the biology of insulin-producing cells destroyed in type 1 diabetes to improvements in islet cell transplantation.

At City of Hope, surgeons perform islet cell transplantation, in which cells from a donor pancreas are transplanted into patients. The Juvenile Diabetes Research Foundation has designated the institution as one of its 14 official islet cell transplant centers in the United States.

Although insulin injection is still the standard treatment for type 1s, transplantation of healthy insulin-producing cells represents an alternative or supplement to insulin injection.

Niland discussed national movements in transplantation. She updated attendees on an umbrella group called the National Islet Cell Resource Consortium, which monitors distribution of islets for transplant or research. Niland reported growing demand for islets and described the organization's efforts to optimize and standardize shipping of the fragile tissues to ensure quality.

Islet quality was also a concern of Daniel R. Salomon, MD, associate professor at The Scripps Research Institute in La Jolla, Calif., who reported on a collaboration with City of Hope scientist Fouad R. Kandeel, MD, PhD, director of the Department of Diabetes, Endocrinology & Metabolism. Salomon and Kandeel have identified a gene expression pattern characteristic of healthy islets. Such gene signatures, or biomarkers, can be used to ensure islets' quality before transplantation.

Other Topics Explored

Topics went beyond transplantation, however. Natarajan, for one, described her search for genomic changes associated with type 1 diabetes.

Natarajan's group looked for these changes, called histone methylation, in genes from patients' blood cells. They compared cells from people with diabetes to those from healthy people. They found that histone methylation patterns in genes associated with inflammation differed between the groups, suggesting that the changes may switch genes on inappropriately. Now the group wants to understand what stimulates such changes.

The symposium is named for the late Rachmiel Levine, MD, a notable diabetes researcher and City of Hope executive medical director in the 70s and early 80s. During his tenure, a team that included Arthur Riggs, PhD, professor of biology and director emeritus of Beckman Research Institute, and Keiichi Itakura, PhD, a professor of molecular biology, developed synthetic human insulin, the world's first genetically engineered drug.

Primary supporters for the symposium included the Susan Gonda (Goldschmied) Diabetes and Genetics Research Center, the Southern California Islet Cell Resources Center, and the Juvenile Diabetes Research Foundation.

Click Here To View Or Post Comments

Categories: Diabetes, Diabetes, Insulin, Islet & Pancreas Transplant, Professional Issues, Type 1 Issues


Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Latest
Popular
Top Rated
Print | Email | Share | Comments (4)

You May Also Be Interested In...


Comments

Posted by bdebruler on 15 February 2008

"Although insulin injection is still the standard treatment for type 1s, transplantation of healthy insulin-producing cells represents an alternative or supplement to insulin injection."

Wow, what an understatement! Transplantation represents a cure for type 1 diabetes... once all the issues of protecting the transplanted cells from the immune system are worked out.

Posted by mjensentulsa on 15 February 2008

I couldn't disagree more with the statement that transplantation represents a cure. We've seen much more promising research that shows that islets will regenerate if the underlying autoimmune response is turned off. Denise Faustman's research into a low-cost (YEAH! THAT'S IMPORTANT) pharmaceutical autoimmune neutralizer, and other interesting stuff about a potential neurological "switch" for triggering the autoimune response is much more likely to lead to a true cure.

The human transplant, biofarm transplant and (ewww!) xeno-pig-transplant is a Big Science/Big Business approach to come up with yet another multibillion dollar therapy that will reach only a fraction of diabetics, and comes with a profit-centered long-term revenue stream for antirejection drugs.

We need the PURCHASERS of healthcare to come up with a "market-based" solution that serves them, not the VENDORS of health products and services to come up with a solution that serves them.

My biggest fear is that the medico-pharma industries will see the threat of the true cure research and buy up all the intellectual property rights. If they did that, they could keep the low-cost approach quite literally bottled up while they push transplants and biotech "cures" at $100,000+ per customer....

Posted by Anonymous on 15 February 2008

My type 1 Diabetes was caused by a defective antibiotic called TEQUIN, it kill all the producting insulin cells after being on it for more then a week. This was seven years ago. Maybe now a transplant will work better for me Where do I sign up. I amslowly dying of this disease and I am willing to do anything to find a cure. I was 47 years old when given this antibiotic within a two month period span.

Posted by Shockmaindave on 16 February 2008

Transplantation is just running in place with a more complicated and expensive treadmill.

Thanks to Dr. Natarajan for researching histone methylation. I'm beginning to feel cured already.


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...


Username: Password:
Comment:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.